Most new chemical entity medicines to-day are biological in origin. Due to the inherent variability of biological systems, the concept of biosimilar medicines rather than multisource/generic biological medicines is applied by health authorities’ worldwide. This one day targeted training focuses on meeting the requirements for registration of a Biosimilar Medicine.

  • Registration of Biosimilar Medicines
  • What must be studied and compared
  • Process of doing a comparability study
  • Case Study
  • Issues you are likely to encounter